Sign in
4

Changes in Ownership

Black Diamond Therapeutics, Inc. Filed Acc 0001209191-22-020012

Director acquired 4,346 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Behbahani Ali · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-18 Grant or award : show line 1 in the form +4,346 $3.02 $13,125 9,705 D
Loading xslF345X03/doc4.xml…